Placental histology and neutrophil extracellular traps in lupus and pre-eclampsia pregnancies

Lupus Science and Medicine

Volumn 3, Issue 1, 2016, Pages

  Marder, Wendy ^a   Knight, Jason S ^a   Kaplan, Mariana J ^b   Somers, Emily C ^a,c   Zhang, Xu ^a   O'Dell, Alexander A ^a   Padmanabhan, Vasantha ^a,c   Lieberman, Richard W ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Autoimmune Diseases; pregnancy; Systemic Lupus Erythematosus

Indexed keywords

MYELOPEROXIDASE;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CONTROLLED STUDY; EXTRACELLULAR TRAP; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERVILLOUS SPACE; INTRAUTERINE GROWTH RETARDATION; LIVER VEIN THROMBOSIS; OLIGOHYDRAMNIOS; PILOT STUDY; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; SPLENIC VEIN THROMBOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; VEIN THROMBOSIS;

EID: 85007218050     PISSN: None     EISSN: 20538790     Source Type: Journal    
DOI: 10.1136/lupus-2015-000134     Document Type: Article

References (52)

1. Gordon C. Pregnancy and autoimmune diseases. Best Pract Res Clin Rheumatol 2004;18:359-79.
2. Clowse ME, Jamison M, Myers E, et al. A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol 2008;199:1-12.
3. Clowse MEB, Magder LS, Witter F, et al. The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum 2005;52:514-21.
4. Steegers EA, von Dadelszen P, Duvekot JJ, et al. Pre-eclampsia. Lancet 2010;376:631-44.
5. Magid MS, Kaplan C, Sammaritano LR, et al. Placental pathology in systemic lupus erythematosus: a prospective study. Am J Obstet Gynecol 1998;179:226-34.
6. Knight JS, Kaplan MJ. Lupus neutrophils: "NET" gain in understanding lupus pathogenesis. Curr Opin Rheumatol 2012;24:441-50.
7. Elkon KB, Wiedeman A. Type I IFN system in the development and manifestations of SLE. Curr Opin Rheumatol 2012;24: 499-505.
8. Rao AN, Kazzaz NM, Knight JS. Do neutrophil extracellular traps contribute to the heightened risk of thrombosis in inflammatory diseases? World J Cardiol 2015;7:829-42.
9. Segal AW. The function of the NADPH oxidase of phagocytes and its relationship to other NOXs in plants, invertebrates, and mammals. Int J Biochem Cell Biol 2008;40:604-18.
10. HIRSCH JG, COHN ZA. Degranulation of polymorphonuclear leucocytes following phagocytosis of microorganisms. J Exp Med 1960;112:1005-14.
11. Keshari RS, Jyoti A, Dubey M, et al. Cytokines induced neutrophil extracellular traps formation: implication for the inflammatory disease condition. PLoS ONE 2012;7:e48111.
12. Gupta AK, Hasler P, Holzgreve W, et al. Induction of neutrophil extracellular DNA lattices by placental microparticles and IL-8 and their presence in preeclampsia. Hum Immunol 2005;66:1146-54.
13. Behnen M, Leschczyk C, Möller S, et al. Immobilized immune complexes induce neutrophil extracellular trap release by human neutrophil Granulocytes via Fc RIIIB and Mac-1. J Immunol 2014;193:1954-65.
14. Villanueva E, Yalavarthi S, Berthier CC, et al. Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. J Immunol 2011;187:538-52.
15. Andrews RK, Arthur JF, Gardiner EE. Neutrophil extracellular traps (NETs) and the role of platelets in infection. Thromb Haemost 2014;112:659-65.
16. Yalavarthi S, Gould TJ, Rao AN, et al. Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome. Arthritis Rheumatol 2015;67: 2990-3003.
17. Zhang S, Lu X, Shu X, et al. Elevated plasma cfDNA may be associated with active lupus nephritis and partially attributed to abnormal regulation of neutrophil extracellular traps (NETs) in patients with systemic lupus erythematosus. Intern Med 2014;53:2763-71.
18. Garcia-Romo GS, Caielli S, Vega B, et al. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med 2011;3:73ra20.
19. Lande R, Ganguly D, Facchinetti V, et al. Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci Transl Med 2011;3:73ra19.
20. Kessenbrock K, Krumbholz M, Schönermarck U, et al. Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med 2009;15:623-5.
21. Gupta AK, Hasler P, Holzgreve W, et al. Neutrophil NETs: a novel contributor to preeclampsia-associated placental hypoxia? Semin Immunopathol 2007;29:163-7.
22. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
23. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
24. Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999;42:1309-11.
25. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306.
26. Clark EA, Silver RM, Branch DW. Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome? Curr Rheumatol Rep 2007;9:219-25.
27. Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988;158:892-8.
28. Benirschke K, Burton GJ, Baergen RN. Pathology of the human placenta. 6th edn. Berlin Heidelberg: Springer-Verlag, 2012.
29. Salafia CM, Popek EJ. Inflammatory and Vascular Placental Pathology. Glob Libr Women's Med 2009. http://www.glowm.com/ index.html?p=glowm.cml/sectionview&articleid=152 (accessed 15. Sep 2014).
30. Khandpur R, Carmona-Rivera C, Vivekanandan-Giri A, et al. NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med 2013;5:178ra40.
31. Callahan TL. Blueprints obstetrics and gynecology. CA: Lippincott Williams &Wilkins, 2008.
32. Gordon P, Beedham T, Khamashta M, et al. Systemic lupus erythematosus in pregnancy. Obstet Gynaecol 2004;6:80-7.
33. Hahn S, Giaglis S, Hoesli I, et al. Neutrophil NETs in reproduction: from infertility to preeclampsia and the possibility of fetal loss. Front Immunol 2012;3:362.
34. Manzi S, Selzer F, Sutton-Tyrrell K, et al. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum 1999;42:51-60.
35. Rajagopalan S, Somers EC, Brook RD, et al. Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensity. Blood 2004;103:3677-83.
36. Bruce IN, Burns RJ, Gladman DD, et al. Single photon emission computed tomography dual isotope myocardial perfusion imaging in women with systemic lupus erythematosus. I. Prevalence and distribution of abnormalities. J Rheumatol 2000;27:2372-7.
37. Urowitz MB, Gladman D, Ibañez D, et al. Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort. Arthritis Rheum 2008;59:176-80.
38. Urowitz MB, Bookman AA, Koehler BE, et al. The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 1976;60:221-5.
39. Manzi S, Meilahn EN, Rairie JE, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997;145:408-15.
40. Kessous R, Shoham-Vardi I, Pariente G, et al. Long-term maternal atherosclerotic morbidity in women with pre-eclampsia. Heart 2015;101:442-6.
41. Funai EF, Friedlander Y, Paltiel O, et al. Long-term mortality after preeclampsia. Epidemiology 2005;16:206-15.
42. Allaire A. Placental apoptosis in preeclampsia. Obstet Gynecol 2000;96:271-6.
43. Knight JS, Kaplan MJ. Cardiovascular disease in lupus: insights and updates. Curr Opin Rheumatol 2013;25:597-605.
44. Denny MF, Yalavarthi S, Zhao W, et al. A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs. J Immunol 2010;184:3284-97.
45. Carmona-Rivera C, Zhao W, Yalavarthi S, et al. Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2. Ann Rheum Dis 2015;74:1417-24.
46. Fert-Bober J, Leon H, Sawicka J, et al. Inhibiting matrix metalloproteinase-2 reduces protein release into coronary effluent from isolated rat hearts during ischemia-reperfusion. Basic Res Cardiol 2008;103:431-43.
47. Montagnana M, Lippi G, Albiero A, et al. Evaluation of metalloproteinases 2 and 9 and their inhibitors in physiologic and pre-eclamptic pregnancy. J Clin Lab Anal 2009;23:88-92.
48. Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992;35:630-40.
49. Clark CA, Spitzer KA, Laskin CA. Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period. J Rheumatol 2005;32:1709-12.
50. Jain V, Gordon C. Managing pregnancy in inflammatory rheumatological diseases. Arthritis Res Ther 2011;13:206.
51. Khamashta MA. Systemic lupus erythematosus and pregnancy. Best Pract Res Clin Rheumatol 2006;20:685-94.
52. Buyon JP, Kim MY, Guerra MM, et al. Predictors of pregnancy outcomes in patients with lupus: a cohort study. Ann Intern Med 2015;163:153-63.